Kalbe Farma Tbk vs Merck Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 19.4× Merck Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 37.6K). Which is the better fit depends on your goals.
| KLBF | MERK | |
|---|---|---|
Market Cap | 33T | 1.7T |
Volume | 98.44M | 37.6K |
Lot | 984.38K | 376 |
Turnover | 70.64B | 144.47M |
Average Price | 717.58 | 3,842.23 |
Value | 70.64B | 144.47M |
Indicative Equilibrium Price | 720 | 3,840 |
Indicative Equilibrium Volume | 43.62K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →